Jemperli 500 mg/10 mL (50 mg/mL) injection Images

Generic Name: dostarlimab

This medication has been identified as Jemperli 500 mg/10 mL (50 mg/mL) injection. It is supplied by GlaxoSmithKline.

Jemperli is used in the treatment of Solid Tumors; Endometrial Cancer and belongs to the drug class anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors). Jemperli 500 mg/10 mL (50 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Jemperli

Generic Name

dostarlimab

Strength

500 mg/10 mL (50 mg/mL) injection

Availability

Prescription only

Drug Class

Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)

CSA Schedule

Not a controlled drug

Labeler / Supplier

GlaxoSmithKline

National Drug Code (NDC)

00173-0898

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer